Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare CVE:ONV NYSE:PLX NYSE:SCD CVE:VGN On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeONVOronova EnergyC$0.07-7.1%C$0.06C$0.04▼C$0.10C$2.83MN/A75,187 shs64,713 shsPLXProtalix BioTherapeutics$2.06$2.10$1.32▼$3.19$165.98M-0.021.03 million shs228,216 shsSCDLMP Capital and Income Fund$15.64+0.1%$15.29$13.79▼$16.18N/AN/A68,901 shs45,232 shsVGNGreencastle ResourcesC$0.03-16.7%C$0.03C$0.03▼C$0.06C$1.44M-0.15371760,102 shs496,000 shs7 Stocks to Buy Before the Robotics RevolutionRobotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceONVOronova Energy0.00%0.00%0.00%0.00%0.00%PLXProtalix BioTherapeutics-1.44%+5.10%+4.04%-26.16%+38.26%SCDLMP Capital and Income Fund+1.23%+1.59%+1.99%+1.63%-2.25%VGNGreencastle Resources0.00%0.00%-14.29%-25.00%0.00%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeONVOronova EnergyC$0.07-7.1%C$0.06C$0.04▼C$0.10C$2.83MN/A75,187 shs64,713 shsPLXProtalix BioTherapeutics$2.06$2.10$1.32▼$3.19$165.98M-0.021.03 million shs228,216 shsSCDLMP Capital and Income Fund$15.64+0.1%$15.29$13.79▼$16.18N/AN/A68,901 shs45,232 shsVGNGreencastle ResourcesC$0.03-16.7%C$0.03C$0.03▼C$0.06C$1.44M-0.15371760,102 shs496,000 shs7 Stocks to Buy Before the Robotics RevolutionRobotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceONVOronova Energy0.00%0.00%0.00%0.00%0.00%PLXProtalix BioTherapeutics-1.44%+5.10%+4.04%-26.16%+38.26%SCDLMP Capital and Income Fund+1.23%+1.59%+1.99%+1.63%-2.25%VGNGreencastle Resources0.00%0.00%-14.29%-25.00%0.00%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceONVOronova Energy 0.00N/AN/AN/APLXProtalix BioTherapeutics 3.00Buy$12.00482.52% UpsideSCDLMP Capital and Income Fund 0.00N/AN/AN/AVGNGreencastle Resources 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest VGN, SCD, PXEN, ONV, and PLX Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails3/19/2026PLXProtalix BioTherapeutics HC WainwrightSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$12.00(Data available from 6/16/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookONVOronova EnergyN/AN/AC$0.00 per share35.00C($0.01) per shareN/APLXProtalix BioTherapeutics$76.38M2.17$0.12 per share17.80$0.47 per share4.38SCDLMP Capital and Income Fund-$68.04KN/AN/AN/AN/AN/AVGNGreencastle ResourcesC$57.41K25.13C$0.07 per share0.38C$0.07 per share0.36Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateONVOronova EnergyN/A-C$0.02N/AN/AN/AN/AN/AN/AN/APLXProtalix BioTherapeutics$8.31M$0.18N/A6.65N/A-21.03%-30.89%-11.74%N/ASCDLMP Capital and Income FundN/AN/AN/AN/AN/AN/AN/AN/AN/AVGNGreencastle Resources-C$6.75M-C$0.03N/AN/AN/AN/A-116.19%-71.68%N/ACompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthONVOronova EnergyN/AN/AN/AN/AN/APLXProtalix BioTherapeuticsN/AN/AN/AN/AN/ASCDLMP Capital and Income Fund$1.449.21%N/AN/AN/AVGNGreencastle ResourcesN/AN/AN/AN/AN/ALatest VGN, SCD, PXEN, ONV, and PLX DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date5/14/2026SCDLMP Capital and Income Fundmonthly$0.129.34%8/24/20268/24/20268/31/20265/14/2026SCDLMP Capital and Income Fundmonthly$0.129.34%7/24/20267/24/20267/31/20265/14/2026SCDLMP Capital and Income Fundmonthly$0.129.34%6/23/20266/23/20266/30/2026(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioONVOronova EnergyN/A0.190.19PLXProtalix BioTherapeuticsN/A1.981.27SCDLMP Capital and Income FundN/AN/AN/AVGNGreencastle Resources0.1317.28220.64Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipONVOronova EnergyN/APLXProtalix BioTherapeutics16.53%SCDLMP Capital and Income FundN/AVGNGreencastle Resources10.83%Insider OwnershipCompanyInsider OwnershipONVOronova EnergyN/APLXProtalix BioTherapeutics6.50%SCDLMP Capital and Income FundN/AVGNGreencastle Resources19.56%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableONVOronova EnergyN/A43.60 millionN/ANot OptionablePLXProtalix BioTherapeutics20080.57 million69.00 millionOptionableSCDLMP Capital and Income Fund1,689N/AN/ANot OptionableVGNGreencastle ResourcesN/A57.71 millionN/ANot OptionableVGN, SCD, PXEN, ONV, and PLX HeadlinesRecent News About These CompaniesGreencastle Raises $200,000 in Insider-Backed Private PlacementMarch 23, 2026 | tipranks.comGreencastle Resources Takes Strategic Stake in Green Shift Commodities via All-Share DealJanuary 19, 2026 | tipranks.comGreencastle Resources Completes Strategic Acquisition of Royal Uranium SharesDecember 5, 2025 | tipranks.comGreencastle Resources Acquires Stake in Royal UraniumNovember 18, 2025 | tipranks.comClosing Bell: Greencastle Res Ltd down on Thursday (VGN)May 27, 2024 | theglobeandmail.comClosing Bell: Greencastle Res Ltd up on Thursday (VGN)May 22, 2024 | theglobeandmail.comVeronica Pejril seeks Democrat nod in Senate District 24April 30, 2024 | bannergraphic.comBMeadow Gambacurta helps Greencastle-Antrim get by WaynesboroApril 23, 2024 | pennlive.comPCold Spring Solar to host open house in Greencastle March 26March 13, 2024 | bannergraphic.comBGreencastle Announces Disposition of Common Shares of Highrock ResourcesMarch 7, 2024 | finance.yahoo.comCommissioners table solar rezone requestFebruary 5, 2024 | bannergraphic.comBHighrock Resources Ltd.: Highrock Appoints Transaction Oriented CEO and DirectorJanuary 11, 2024 | finanznachrichten.deHighrock Resources Ltd.: Highrock Announces Appointment of Chief Financial OfficerOctober 30, 2023 | finanznachrichten.deGreencastle Resources Ltd.: Greencastle Announces Acquisition of Common Shares of Highrock ResourcesSeptember 22, 2023 | finanznachrichten.deGreencastle Announces Acquisition of Common Shares of Highrock ResourcesSeptember 13, 2023 | finance.yahoo.comClosing Bell: Greencastle Res Ltd up on Friday (VGN)August 26, 2023 | theglobeandmail.comClosing Bell: Greencastle Res Ltd down on Wednesday (VGN)August 23, 2023 | theglobeandmail.comGreencastle Announces Cancellation of Stock OptionsJune 8, 2023 | finance.yahoo.comClosing Bell: Greencastle Res Ltd flat on Monday (VGN)April 26, 2023 | theglobeandmail.comClosing Bell: Greencastle Res Ltd flat on Friday (VGN)April 25, 2023 | theglobeandmail.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesThe SpaceX IPO Frenzy Is Creating 2 Very Different BetsBy Jeffrey Neal Johnson | May 27, 2026A Deep Dive Into NVIDIA’s Latest Portfolio MovesBy Leo Miller | May 19, 2026These 3 Beaten-Down Stocks Just Saw $25 Million in Insider BuyingBy Leo Miller | May 28, 2026Mirum Pharma: A Rare Disease Growth Story to WatchBy Chris Markoch | May 20, 2026Casey’s Is Looking Like a Hot Buy as Growth, Buybacks, and Guidance AlignBy Thomas Hughes | June 11, 2026VGN, SCD, PXEN, ONV, and PLX Company DescriptionsOronova Energy CVE:ONVC$0.06 -0.01 (-7.14%) As of 02/13/2020Oronova Energy Inc., a development stage company, engages in the acquisition, exploration, development, and production of crude oil and natural gas reserves in Latin America. It intends to seek for oil and gas opportunities in Latin America. The company was formerly known as Oronova Resource Corp. and changed its name to Oronova Energy Inc. in December 2016. Oronova Energy Inc. is based in Vancouver, Canada.Protalix BioTherapeutics NYSE:PLX$2.06 0.00 (0.00%) Closing price 04:00 PM EasternExtended Trading$2.05 -0.01 (-0.34%) As of 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Protalix BioTherapeutics, Inc., a biopharmaceutical company, engages in the development, production, and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in the United States, Australia, Canada, Israel, Brazil, Russia, Turkey, and internationally. The company offers Elelyso for the treatment of Gaucher disease; and Elfabrio for the treatment of adult patients with a confirmed diagnosis of Fabry disease. It is also developing PRX-115, a plant cell-expressed recombinant PEGylated Uricase which is in Phase I trial for the treatment of gout; and PRX-119, a plant cell-expressed PEGylated recombinant human DNase I product candidate that is in preclinical phase for the treatment of NETs-related diseases. The company has agreements and partnerships with Pfizer; Fundação Oswaldo Cruz; and Chiesi Farmaceutici S.p.A. The company was incorporated in 1993 and is headquartered in Karmiel, Israel. Protalix BioTherapeutics, Inc. is a subsidiary of Protalix Ltd.LMP Capital and Income Fund NYSE:SCD$15.64 +0.02 (+0.13%) Closing price 03:58 PM EasternExtended Trading$15.64 0.00 (0.00%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.LMP Capital and Income Fund Inc. is a closed ended balanced mutual fund launched and managed by Legg Mason Partners Fund Advisor, LLC. It is co-managed by Clearbridge Investments, LLC, Western Asset Management Company Limited, and Western Asset Management Company. The fund invests in public equity and fixed income markets across the globe. It seeks to invest in securities of companies operating across diversified sectors. The fund primarily invests in stocks of large-cap companies, intermediate period corporate bonds and notes rated at least A-, energy and non-energy master limited partnerships, and real estate investment trusts. It focuses on such factors as economic, market, or political conditions, fiscal and monetary policy, and security valuation to create its portfolio. The fund benchmarks the performance of its portfolio against the U.S. Aggregate Index and S&P 500 Index. It was formerly known as Salomon Brothers Capital and Income Fund Inc. LMP Capital and Income Fund Inc. was formed on November 12, 2003 and is domiciled in the United States.Greencastle Resources CVE:VGNC$0.02 -0.01 (-16.67%) As of 03:18 PM EasternGreencastle Resources Ltd., together with its subsidiaries, engages in the exploration and development of gold, base metal, oil and gas properties, and royalties in Canada. The company operates through Investments in Private and Public Companies; Oil and Gas Interests; and Mining Interests segments. It holds interests in the Jewel Ridge gold property located in Nevada, the United States; the Primate oil and gas property in Saskatchewan; and the Ferrier oil and gas project located in Alberta. The company also holds royalty interests in wells located in the Spirit River area, Alberta. Greencastle Resources Ltd. was founded in 1996 and is headquartered in Toronto, Canada. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Gravity Check: Houston, SpaceX Has a Valuation Problem Okta’s AI Moment May Be Bigger Than Investors Realize Strategy’s Bitcoin Rally Has a Hidden Engine Is Lennar Finally Turning the Corner After Its Housing Slump? Plot Twist: How the $110B Paramount-Warner Deal Rewrites Media AST SpaceMobile Announces Launch Date for Its Next 3 BlueBird Satellites Insiders Sell Top Tech Plays: Should Investors Buy, Sell, or Hold? What's Behind the Social Media Controversy Surrounding IonQ? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
